Metrion Biosciences' Business Development Executive Dr Anca Haralambie will be attending On Helix Digital 2021 which takes place on 5th and 6th July. On Helix is the One Nucleus flagship conference, bringing together professionals within the One Nucleus network to present and discuss the main innovation and technology trends in healthcare research and development. Throughout [...]
Metrion's Sales and Marketing Manager Dr Sophie Rose and Business Development Executive Dr Anca Haralambie will be attending "Translating Ideas into Therapies 2021", Co-hosted by ELRIG and the British Pharmacological Society. The event takes place between Wednesday, 30 June 2021 and Thursday, 1 July 2021 and will be held virtually. Metrion Biosciences is a UK-based [...]
Metrion's Business Development Executive Anca Haralambie will be attending Nordic Life Science Days to be held virtually from 20th to 23rd April 2021. More details of the event can be found here. If you would like to arrange a partnering meeting with Anca please email info@metrionbiosciences.com NLSDays conference program available “LIVE” on 20-21 April then [...]
Metrion Biosciences closes £2.7m new equity financing • Financing led by Gresham House Ventures • Funds to be used to enhance Metrion’s Cambridge, UK ion channel drug discovery laboratories and capabilities and expand its presence in the USA • Maya Ward, Associate Director, Gresham House Ventures, appointed to Metrion Board of Directors Cambridge, UK, [...]
The Drug Discovery for Ion Channels XXII Satellite Meeting A global pandemic wasn’t going to stand in our way Nothing was going to prevent this annual gathering of ion channel enthusiasts and drug discovery professionals from taking place. Planning got underway in late 2020 to facilitate the virtual organisation and smooth running of the [...]
Metrion's Sales and Marketing Manager Dr Sophie Rose and Business Development Executive Anca Haralambie will be attending the third CRISPR in Drug Discovery: From Targets to Therapeutics meeting hosted by ELRIG, to be held on 23rd and 24th March 2021 as a virtual event. The event will focus on the application of genome engineering to [...]
Metrion Biosciences will be attending the Biophysical Society Annual Meeting to be hosted virtually from 22nd to 26th February 2021. Metrion will be presenting two posters and taking part in the virtual exhibition at the event. Please keep an eye on our website for more information as the event date approaches. If you would like [...]
Metrion is co-organising and attending the 'Drug Discovery for Ion Channels XXII' Virtual satellite meeting. This is a collaborative meeting, organised alongside partners Nanion, Sophion, Fluxion and SB Drug Discovery. The final line-up of Speakers is given below and can also be found here. The event will start at 8AM PST / 4PM GMT/ 5PM [...]
Metrion Biosciences appoints John Montana as Non-Executive Director Expansion of the Board of Directors will support the company’s further growth as an ion channels focused drug discovery CRO Cambridge, UK, 09 February 2021: Metrion Biosciences Limited (“Metrion”), the specialist ion channel contract research and drug discovery company, today announced the appointment of John Montana, [...]
Metrion Biosciences and Sosei Heptares to Explore Structure-based Drug Discovery (SBDD) Approaches to Ion Channels through Strategic Technology Collaboration • Ion channels represent a large but under-exploited class of drug targets beyond G protein-coupled receptors (GPCRs) • Collaboration combines Sosei Heptares’ leading structure-based drug design platform with Metrion Biosciences’ ion channel expertise • Joint [...]
